Insight Pharma Reports
Menu
  1. Home
  2. All Reports
  3. Publishers
  4. Delve Insight

Delve Insight

Picture of Ubiquitin conjugating enzyme Inhibitor -Pipeline Insight, 2018
Ubiquitin conjugating enzyme Inhibitor -Pipeline Insight, 2018

September 2018

From $1,250.00

Picture of Ubiquitin Specific Proteases (USP) Inhibitor -Pipeline Insight, 2018
Ubiquitin Specific Proteases (USP) Inhibitor -Pipeline Insight, 2018

September 2018

From $1,250.00

Picture of Optruma API Insight 2018
Optruma API Insight 2018

July 2018

From $500.00

Picture of Uveitis - Market Insights, Epidemiology and Market Forecast – 2025
Uveitis - Market Insights, Epidemiology and Market Forecast – 2025

November 2017

From $5,750.00

Picture of Liver Fibrosis-Pipeline Insights, 2016
Liver Fibrosis-Pipeline Insights, 2016

October 2016

From $1,250.00

Picture of Liver Cirrhosis-Pipeline Insights, 2016
Liver Cirrhosis-Pipeline Insights, 2016

October 2016

From $1,250.00

Picture of Chronic Liver Disease-Pipeline Insights, 2016
Chronic Liver Disease-Pipeline Insights, 2016

October 2016

From $1,250.00

Picture of Metastatic Liver Cancer-Pipeline Insights, 2016
Metastatic Liver Cancer-Pipeline Insights, 2016

October 2016

From $1,250.00

Picture of Non Alcoholic Fatty Liver Disease (NAFLD)-Pipeline Insights, 2016
Non Alcoholic Fatty Liver Disease (NAFLD)-Pipeline Insights, 2016

October 2016

From $1,250.00

Picture of Hepatic (Liver) Tumor-Pipeline Insights, 2016
Hepatic (Liver) Tumor-Pipeline Insights, 2016

October 2016

From $1,250.00

Picture of Fatty Liver Disease-Pipeline Insights, 2016
Fatty Liver Disease-Pipeline Insights, 2016

October 2016

From $1,250.00

Picture of Liver Cirrhosis-Global API Manufacturers, Marketed and Phase III Drugs
Liver Cirrhosis-Global API Manufacturers, Marketed and Phase III Drugs

October 2016

From $2,000.00

Picture of Liver Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Liver Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

October 2016

From $2,000.00

Picture of Amebic Liver Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Amebic Liver Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

October 2016

From $2,000.00

Picture of Human papillomavirus (HPV) Associated Cancer-Pipeline Insights, 2016
Human papillomavirus (HPV) Associated Cancer-Pipeline Insights, 2016

October 2016

From $1,250.00

Picture of Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023
Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

September 2016

From $4,950.00

Picture of Graves Disease - Market Insights, Epidemiology and Market Forecast-2023
Graves Disease - Market Insights, Epidemiology and Market Forecast-2023

September 2016

From $4,950.00

Picture of Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023
Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023

September 2016

From $4,950.00

Picture of Guillain-Barre Syndrome (GBS)-Market Insights, Epidemiology and Market Forecast-2023
Guillain-Barre Syndrome (GBS)-Market Insights, Epidemiology and Market Forecast-2023

September 2016

From $4,950.00

Picture of Juvenile idiopathic arthritis (JIA)- Market Insights, Epidemiology and Market Forecast-2023
Juvenile idiopathic arthritis (JIA)- Market Insights, Epidemiology and Market Forecast-2023

September 2016

From $4,950.00

Picture of Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

August 2016

From $2,000.00

Picture of Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2016
Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2016

July 2016

From $1,250.00

Picture of Gallbladder Cancer-Pipeline Insights, 2016
Gallbladder Cancer-Pipeline Insights, 2016

July 2016

From $1,250.00

Picture of Acute Respiratory Distress Syndrome-Pipeline Insights, 2016
Acute Respiratory Distress Syndrome-Pipeline Insights, 2016

July 2016

From $1,250.00

Picture of Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

June 2016

From $2,000.00

Picture of Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

June 2016

From $2,000.00

Picture of Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2016
Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2016

June 2016

From $1,250.00

Picture of Parkinson's Disease-Global API Manufacturers, Marketed and Phase III
Parkinson's Disease-Global API Manufacturers, Marketed and Phase III

June 2016

From $2,000.00

Picture of Dementia Associated With Alzheimers Disease-Pipeline Insights, 2016
Dementia Associated With Alzheimers Disease-Pipeline Insights, 2016

June 2016

From $1,250.00

Picture of Alzheimers Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Alzheimers Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

June 2016

From $2,000.00

Picture of Amyloid Protein Blockers -Pipeline Insights, 2016
Amyloid Protein Blockers -Pipeline Insights, 2016

May 2016

From $1,250.00

Picture of Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016

May 2016

From $2,950.00

Picture of Ocular Inflammation-Pipeline Insights, 2016
Ocular Inflammation-Pipeline Insights, 2016

May 2016

From $1,250.00

Picture of Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2016
Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2016

May 2016

From $1,250.00

Picture of Pediatric Cancer-Pipeline Insights, 2016
Pediatric Cancer-Pipeline Insights, 2016

May 2016

From $1,250.00

Picture of Attention Deficit Hyperactivity Disorder (ADHD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Attention Deficit Hyperactivity Disorder (ADHD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

May 2016

From $2,000.00

Picture of Diabetic Neuropathy-Pipeline Insights, 2016
Diabetic Neuropathy-Pipeline Insights, 2016

March 2016

From $1,250.00

Picture of Type 1 Diabetes (Juvenile Diabetes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Type 1 Diabetes (Juvenile Diabetes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

March 2016

From $2,000.00

Picture of Bone Metastasis-Pipeline Insights, 2016
Bone Metastasis-Pipeline Insights, 2016

March 2016

From $1,250.00

Picture of Bone Metastasis-API Insights, 2015
Bone Metastasis-API Insights, 2015

March 2016

From $1,250.00

Picture of Bone Marrow Transplantation-Pipeline Insights, 2016
Bone Marrow Transplantation-Pipeline Insights, 2016

March 2016

From $1,250.00

Picture of Head And Neck Cancer-API Insights, 2015
Head And Neck Cancer-API Insights, 2015

March 2016

From $1,250.00

Picture of Diabetic Macular Edema-Pipeline Insights, 2016
Diabetic Macular Edema-Pipeline Insights, 2016

March 2016

From $1,250.00

Report Topics

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Copyright © 2022 Insight Pharma Reports. All rights reserved.
Powered by nopCommerce